81 related articles for article (PubMed ID: 24080835)
1. Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model.
Ito Y; Nozaki M; Sugitani K; Ashikari M; Hirano Y; Ogura Y
Ophthalmologica; 2013; 230(4):215-21. PubMed ID: 24080835
[TBL] [Abstract][Full Text] [Related]
2. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
4. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
6. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
[TBL] [Abstract][Full Text] [Related]
7. A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model.
Liu HA; Liu YL; Ma ZZ; Wang JC; Zhang Q
Invest Ophthalmol Vis Sci; 2011 Jul; 52(7):4789-94. PubMed ID: 21519028
[TBL] [Abstract][Full Text] [Related]
8. Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.
Poor SH; Qiu Y; Fassbender ES; Shen S; Woolfenden A; Delpero A; Kim Y; Buchanan N; Gebuhr TC; Hanks SM; Meredith EL; Jaffee BD; Dryja TP
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6525-34. PubMed ID: 25205860
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice.
Mizutani T; Fowler BJ; Kim Y; Yasuma R; Krueger LA; Gelfand BD; Ambati J
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7122-9. PubMed ID: 26529046
[TBL] [Abstract][Full Text] [Related]
11. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.
Kleinman ME; Yamada K; Takeda A; Chandrasekaran V; Nozaki M; Baffi JZ; Albuquerque RJ; Yamasaki S; Itaya M; Pan Y; Appukuttan B; Gibbs D; Yang Z; Karikó K; Ambati BK; Wilgus TA; DiPietro LA; Sakurai E; Zhang K; Smith JR; Taylor EW; Ambati J
Nature; 2008 Apr; 452(7187):591-7. PubMed ID: 18368052
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor.
Fukuhara J; Noda K; Murata M; Namba S; Kinoshita S; Dong Z; Ando R; Lennikov A; Kanda A; Ishida S
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):274-9. PubMed ID: 23233257
[TBL] [Abstract][Full Text] [Related]
14. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
15. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
[TBL] [Abstract][Full Text] [Related]
18. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
[TBL] [Abstract][Full Text] [Related]
19. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
[TBL] [Abstract][Full Text] [Related]
20. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
